Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Lags Revenue Estimates
Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -1.61% and 100%, respectively, for the quarter ended March 2023. Do…
38,600€
2,12%
Echtzeit-Aktienkurs Xenon Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Xenon Pharmaceuticals Inc. Aktie
Xenon Pharmaceuticals: Q1 Earnings Insights
read more...…
Form 10-Q Xenon Pharmaceuticals For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
BURNABY, British Columbia, April 21, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Xenon Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
BURNABY, British Columbia, April 18, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Insiderhandel: Chief Medical Officer verkauft Aktien von Xenon Pharmaceuticals im Wert von 24.507$
Kenney, Christopher John - Vorstand - Tag der Transaktion: 2023-03-24...…
Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
BURNABY, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Form 8-K Xenon Pharmaceuticals For: Mar 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Xenon Pharmaceuticals For: Mar 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Lags Revenue Estimates
Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of 1.72% and 100%, respectively, for the quarter ended December 2022. Do…
Form 8-K Xenon Pharmaceuticals For: Mar 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharma Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
BURNABY, British Columbia, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
BURNABY, British Columbia, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
BURNABY, British Columbia, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
Company Presents Additional Positive Data from Open Label Extension of Phase 2b X-TOLE Clinical Trial for Focal Onset Seizures...…
Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
BURNABY, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Insiderhandel: Aufsichtsrat verkauft Aktien von Xenon Pharmaceuticals im Wert von 67.390$
Patou, Gary - Aufsichtsrat - Tag der Transaktion: 2022-11-25...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Xenon Pharmaceuticals im Wert von 70.610$
Patou, Gary - Aufsichtsrat - Tag der Transaktion: 2022-11-23...…
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
BURNABY, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…
Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Misses Revenue Estimates
Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -9.62% and 97.94%, respectively, for the quarter ended September 2022. Do…
Form 10-Q Xenon Pharmaceuticals For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Xenon Pharmaceuticals For: Nov 07
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharma Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
BURNABY, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today…